Cargando…
Structure-Based Epitope Design: Toward a Greater Antibody–SARS-CoV-2 RBD Affinity
[Image: see text] Efficient COVID-19 vaccines are widely acknowledged as the best way to end the global pandemic. SARS-CoV-2 receptor-binding domain (RBD) plays fundamental roles related to cell infection. Antibodies could be developed to target RBD and represent a potential approach for the neutral...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637584/ https://www.ncbi.nlm.nih.gov/pubmed/34869973 http://dx.doi.org/10.1021/acsomega.1c03348 |